ProCE Banner Activity

Expert Answers to Frequently Asked and Compelling Questions on Meeting LDL-C Targets

Clinical Thought

Read highlighted expert responses to frequently asked and compelling audience questions from the live symposium, Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies.

Released: May 10, 2024

Expiration: May 09, 2025

Share

Faculty

Michael Miller

Michael Miller, MD, FACC, FAHA

Cardiologist & Professor of Medicine
Hospital of the University of Pennsylvania
Chief of Medicine
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Disclosure

Primary Author

Michael Miller, MD, FACC, FAHA

Cardiologist & Professor of Medicine
Hospital of the University of Pennsylvania
Chief of Medicine
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Michael Miller, MD, FACC, FAHA: consultant/advisor/speaker: 89bio, Amarin, Ionis.